Xalatan and Eye movement disorder - a phase IV clinical study of FDA data

Summary:

Eye movement disorder is reported as a side effect among people who take Xalatan (latanoprost), especially for people who are female, 60+ old, also take Prilosec, and have Osteoporosis.

The phase IV clinical study analyzes which people have Eye movement disorder when taking Xalatan. It is created by eHealthMe based on reports of 25,196 people who have side effects when taking Xalatan from the FDA, and is updated regularly.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,550 Xalatan users. Check the latest studies of Xalatan.

What is Eye movement disorder?

Eye movement disorder is found to be associated with 609 drugs and 902 conditions by eHealthMe. Check the latest studies of Eye movement disorder.

On Jul, 06, 2026

25,196 people reported to have side effects when taking Xalatan.
Among them, 13 people (0.05%) have Eye movement disorder.

Could Xalatan cause Eye movement disorder?

Among these 13 people:

What is the gender of people who have Eye movement disorder when taking Xalatan? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Eye movement disorder when taking Xalatan? *

What are other drugs people take besides Xalatan? *

What are other side effects people have besides Eye movement disorder? *

Eye Pain: 6 people, 46.15%
Visual Acuity Reduced (reduced clearness of vision): 3 people, 23.08%
Eye Irritation: 3 people, 23.08%
Rashes (redness): 3 people, 23.08%
Photophobia (extreme sensitivity to light): 3 people, 23.08%
Iris Disorder: 2 people, 15.38%
Dizziness: 2 people, 15.38%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 15.38%
Eyelid Disorder: 2 people, 15.38%
Dry Eyes (lack of adequate tears): 2 people, 15.38%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 2 people, 15.38%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 1 person, 7.69%
Pruritus Allergic (severe allergic itching of the skin): 1 person, 7.69%
Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 7.69%
Pain: 1 person, 7.69%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 7.69%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 1 person, 7.69%
Muscle Spasms (muscle contraction): 1 person, 7.69%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 7.69%
Eye Pruritus (eye itching): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Xalatan and have Eye movement disorder?

- Check whether Eye movement disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalatan:

Xalatan (25,550 reports)

Browse all side effects of Xalatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye movement disorder:

Eye movement disorder (609 drugs)

Browse all the conditions that are associated with Eye movement disorder:

Eye movement disorder (902 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Xalatan) and Xalatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.